Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Meyer

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|March 21, 2025
Single-Cell Transcriptomics Identifies a Prominent Role for the MIF-CD74 Axis in Myasthenia Gravis ThymusPaula Terroba-Navajas, I-Na Lu, Isaak Quast, et al.
Cell Reports. Medicine|October 8, 2021
Single-cell RNA-seq unravels alterations of the human spermatogonial stem cell compartment in patients with impaired spermatogenesisSara Di Persio, Tobias Tekath, Lara Marie Siebert-Kuss, et al.
Genome Medicine|June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapyI-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Immunity|December 31, 2020
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal FluidMichael Heming, Xiaolin Li, Saskia Räuber, et al.
EMBO Molecular Medicine|February 27, 2024
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravisDai-Shi Tian, Chuan Qin, Ming-Hao Dong, et al.
Acta Neuropathologica|December 19, 2019
Macrophage-tumor cell interaction promotes ATRT progression and chemoresistanceViktoria Melcher, Monika Graf, Marta Interlandi, et al.
Med (New York, N.Y.)|May 27, 2025
Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathyMing-Hao Dong, Zhi-Cheng Mei, Luo-Qi Zhou, et al.
Cell|December 7, 2021
Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunityAlexandra Schnell, Linglin Huang, Meromit Singer, et al.
Genome Medicine|September 24, 2022
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphomaMichael Heming, Svea Haessner, Jolien Wolbert, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Neurology(R) Neuroimmunology & Neuroinflammation|March 21, 2025
Single-Cell Transcriptomics Identifies a Prominent Role for the MIF-CD74 Axis in Myasthenia Gravis ThymusPaula Terroba-Navajas, I-Na Lu, Isaak Quast, et al.
Cell Reports. Medicine|October 8, 2021
Single-cell RNA-seq unravels alterations of the human spermatogonial stem cell compartment in patients with impaired spermatogenesisSara Di Persio, Tobias Tekath, Lara Marie Siebert-Kuss, et al.
Genome Medicine|June 30, 2025
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapyI-Na Lu, Louisa Müller-Miny, Carolin Krekeler, et al.
Immunity|December 31, 2020
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal FluidMichael Heming, Xiaolin Li, Saskia Räuber, et al.
EMBO Molecular Medicine|February 27, 2024
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravisDai-Shi Tian, Chuan Qin, Ming-Hao Dong, et al.
Acta Neuropathologica|December 19, 2019
Macrophage-tumor cell interaction promotes ATRT progression and chemoresistanceViktoria Melcher, Monika Graf, Marta Interlandi, et al.
Med (New York, N.Y.)|May 27, 2025
Anti-BCMA CAR-T cell therapy in relapsed/refractory chronic inflammatory demyelinating polyneuropathyMing-Hao Dong, Zhi-Cheng Mei, Luo-Qi Zhou, et al.
Cell|December 7, 2021
Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunityAlexandra Schnell, Linglin Huang, Meromit Singer, et al.
Genome Medicine|September 24, 2022
Intratumor heterogeneity and T cell exhaustion in primary CNS lymphomaMichael Heming, Svea Haessner, Jolien Wolbert, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.
Pageof 18